Top Story

T-cell therapy receives FDA’s orphan drug status for soft tissue sarcoma

T-cell therapy receives FDA’s orphan drug status for soft tissue sarcoma
September 9, 2019
Meeting News

IASLC: All physicians should screen patients with cancer for tobacco use

September 7, 2019
BARCELONA — The International Association for the Study of Lung Cancer, or IASLC, today issued a declaration at its World Conference on Lung Cancer advising all…
FDA News

FDA approves pexidartinib, first therapy for tenosynovial giant cell tumor

August 2, 2019
The FDA announced today approved pexidartinib for the treatment of adults with symptomatic tenosynovial giant cell tumor that is linked to functional limitations or…
FDA News

FDA grants priority review to tazemetostat for epithelioid sarcoma

July 25, 2019
The FDA granted priority review to tazemetostat for the treatment of patients with metastatic or locally advanced epithelioid sarcoma who are not eligible for curative…
More Headlines »

2019 Texas Oncology Clinical Educational Symposium

This activity is supported by educational grants from AbbVie, Inc.; Celgene Corporation; Novartis Pharmaceuticals Corporation; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc.; Takeda Oncology; and Verastem, Inc..

Clinical outcomes for advanced cancers continue to improve through the identification as well as the development of…
More »

Baseball great Mike Schmidt became ‘concerned about dying’ after melanoma diagnosis

September 25, 2017
More »

Ace the Case: A 54-year-old Man With 2 Weeks of Progressive Shortness of Breath

There is no commercial support for this activity.

This educational activity will utilize a case study to discuss the management of a 54-year-old man with 2 weeks of…
More »